These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 18182242)

  • 61. Potent bradykinin B1 receptor antagonists: 4-substituted phenyl cyclohexanes.
    Su DS; Lim JL; Markowitz MK; Wan BL; Murphy KL; Reiss DR; Harrell CM; O'Malley SS; Ransom RW; Chang RS; Pettibone DJ; Tang C; Prueksaritanont T; Freidinger RM; Bock MG
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3006-9. PubMed ID: 17428657
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Fate of bradykinin on the rat liver when administered by the venous or arterial route.
    Gioli-Pereira L; Nascimento EA; Santos EL; Bracht A; Juliano MA; Pesquero JB; Borges DR; Kouyoumdjian M
    J Gastroenterol Hepatol; 2005 Mar; 20(3):463-73. PubMed ID: 15740493
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pharmacological and biochemical characterization of bradykinin B2 receptors in the mouse colon: influence of the TNBS-induced colitis.
    Hara DB; Fernandes ES; Campos MM; Calixto JB
    Regul Pept; 2007 Jun; 141(1-3):25-34. PubMed ID: 17276525
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A new class of bradykinin 1 receptor antagonists containing the piperidine acetic acid tetralin core.
    Fotsch C; Biddlecome G; Biswas K; Chen JJ; D'Amico DC; Groneberg RD; Han NB; Hsieh FY; Kamassah A; Kumar G; Lester-Zeiner D; Liu Q; Mareska DA; Riahi BB; Wang YJ; Yang K; Zhan J; Zhu J; Johnson E; Ng G; Askew BC
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2071-5. PubMed ID: 16464576
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Essential role of TM V and VI for binding the C-terminal sequences of Des-Arg-kinins.
    Santos EL; de Picoli Souza K; Cibrián-Uhalte E; Oliveira SM; Bader M; Costa-Neto CM; Oliveira L; Pesquero JB
    Int Immunopharmacol; 2008 Feb; 8(2):282-8. PubMed ID: 18182241
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Novel kinin B1 receptor agonists with improved pharmacological profiles.
    Côté J; Savard M; Bovenzi V; Bélanger S; Morin J; Neugebauer W; Larouche A; Dubuc C; Gobeil F
    Peptides; 2009 Apr; 30(4):788-95. PubMed ID: 19150636
    [TBL] [Abstract][Full Text] [Related]  

  • 67. New bradykinin analogues substituted in positions 7 and 8 with sterically restricted 1-aminocyclopentane-1-carboxylic acid.
    Labudda O; Wierzba T; Sobolewski D; Kowalczyk W; Sleszyńska M; Gawiński L; Plackova M; Slaninová J; Prahl A
    J Pept Sci; 2006 Dec; 12(12):775-9. PubMed ID: 17131289
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pharmacological characterization of ligand-receptor interactions at the zebrafish bradykinin receptor.
    Bromée T; Kukkonen JP; Andersson P; Conlon JM; Larhammar D
    Br J Pharmacol; 2005 Jan; 144(1):11-6. PubMed ID: 15644864
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Blockade of hippocampal bradykinin B1 receptors improves spatial learning and memory deficits in middle-aged rats.
    Bitencourt RM; Guerra de Souza AC; Bicca MA; Pamplona FA; de Mello N; Passos GF; Medeiros R; Takahashi RN; Calixto JB; Prediger RD
    Behav Brain Res; 2017 Jan; 316():74-81. PubMed ID: 27566183
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Structure-activity studies of B1 receptor-related peptides. Antagonists.
    Gobeil F; Neugebauer W; Filteau C; Jukic D; Allogho SN; Pheng LH; Nguyen-Le XK; Blouin D; Regoli D
    Hypertension; 1996 Nov; 28(5):833-9. PubMed ID: 8901831
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A non-peptide antagonist unusually selective for the human form of the bradykinin B2 receptor.
    Marceau F; Fortin JP; Morissette G; Dziadulewicz EK
    Int Immunopharmacol; 2003 Oct; 3(10-11):1529-36. PubMed ID: 12946450
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Antagonist, partial agonist and antiproliferative actions of B-9870 (CU201) as a function of the expression and density of the bradykinin B1 and B2 receptors.
    Morissette G; Houle S; Gera L; Stewart JM; Marceau F
    Br J Pharmacol; 2007 Feb; 150(3):369-79. PubMed ID: 17179948
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Potent, long-acting, orally-active bradykinin antagonists for a wide range of applications.
    Stewart JM; Gera L; Chan DC; Whalley ET; Hanson WL; Zuzack JS
    Immunopharmacology; 1997 Jun; 36(2-3):167-72. PubMed ID: 9228542
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Novel analogues of bradykinin conformationally restricted in the C-terminal part of the molecule.
    Sleszyńska M; Wierzba TH; Malinowski K; Borovičková L; Małuch I; Sobolewski D; Lammek B; Slaninová J; Prahl A
    J Pept Sci; 2011 May; 17(5):366-72. PubMed ID: 21412955
    [TBL] [Abstract][Full Text] [Related]  

  • 75. 2-Aminobenzophenones as a novel class of bradykinin B1 receptor antagonists.
    Su DS; Lim JL; Tinney E; Wan BL; Murphy KL; Reiss DR; Harrell CM; O'Malley SS; Ransom RW; Chang RS; Pettibone DJ; Yu J; Tang C; Prueksaritanont T; Freidinger RM; Bock MG; Anthony NJ
    J Med Chem; 2008 Jul; 51(13):3946-52. PubMed ID: 18553956
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Aryl sulfones as novel bradykinin B1 receptor antagonists for treatment of chronic pain.
    Biswas K; Aya T; Qian W; Peterkin TA; Chen JJ; Human J; Hungate RW; Kumar G; Arik L; Lester-Zeiner D; Biddlecome G; Manning BH; Sun H; Dong H; Huang M; Loeloff R; Johnson EJ; Askew BC
    Bioorg Med Chem Lett; 2008 Sep; 18(17):4764-9. PubMed ID: 18706809
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A nonpeptide antagonist reveals a highly glycosylated state of the rabbit kinin B1 receptor.
    Fortin JP; Dziadulewicz EK; Gera L; Marceau F
    Mol Pharmacol; 2006 Apr; 69(4):1146-57. PubMed ID: 16407468
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Bradykinin B2 type receptor activation regulates fluid and electrolyte transport in the rabbit kidney.
    Hébert RL; Regoli D; Xiong H; Breyer MD; Plante GE
    Peptides; 2005 Aug; 26(8):1308-16. PubMed ID: 16042972
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Non-peptide antagonists for kinin B1 receptors: new insights into their therapeutic potential for the management of inflammation and pain.
    Campos MM; Leal PC; Yunes RA; Calixto JB
    Trends Pharmacol Sci; 2006 Dec; 27(12):646-51. PubMed ID: 17056130
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Enhancement of blood-tumor barrier permeability by Sar-[D-Phe8]des-Arg9BK, a metabolically resistant bradykinin B1 agonist, in a rat C6 glioma model.
    Cardoso RC; Lobão-Soares B; Bianchin MM; Carlotti CG; Walz R; Alvarez-Silva M; Trentin AG; Nicolau M
    BMC Neurosci; 2004 Sep; 5():38. PubMed ID: 15458573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.